Clayton, Dubilier & Rice to Acquire Cynosure

November 21, 2019

Clayton, Dubilier & Rice today announced an agreement under which CD&R-managed funds will acquire Cynosure, LLC, a leader in medical aesthetics systems and technologies, from Hologic, Inc. (NASDAQ:HOLX).
Cynosure develops, manufactures and markets medical aesthetic treatment systems for dermatologists, plastic surgeons, medical spas and other health care practitioners. The company’s broad portfolio of products spans several major categories, including skin revitalization, body contouring, hair removal and women’s health. Cynosure sells its products through a combination of direct sales and distributors in more than 130 countries and supports its provider partners with a range of technical, clinical and support services.
Read more at Clayton, Dubilier & Rice >>

Become a member

Get the tools you need to succeed in the medical spa industry.

Related
    • AmSpa CEO Reflects on the Sonya Dakar Case
    • SkinStylus Receives New FDA Clearance for the Improvement of Periorbital Wrinkles for All Skin Types
    • GlossGenius Becomes Platinum Vendor Affiliate with the American Med Spa Association
    • PDGF, Regenerative Medicine and the Questions Med Spas Can’t Ignore
    • Medicare GLP-1 Bridge Program Launches July 1, Expanding Access for Some Patients